Epigallocatechin gallate inhibits HIF-1α degradation in prostate cancer cells
- 1 August 2005
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 334 (2) , 543-548
- https://doi.org/10.1016/j.bbrc.2005.06.114
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Targeting HIF-1 for cancer therapyNature Reviews Cancer, 2003
- Oxygen sensing in the hypoxic response pathway: regulation of the hypoxia-inducible transcription factorGenes & Development, 2003
- Oxygen Sensing Gets a Second WindScience, 2002
- A Conserved Family of Prolyl-4-Hydroxylases That Modify HIFScience, 2001
- C. elegans EGL-9 and Mammalian Homologs Define a Family of Dioxygenases that Regulate HIF by Prolyl HydroxylationCell, 2001
- Independent function of two destruction domains in hypoxia-inducible factor-α chains activated by prolyl hydroxylationThe EMBO Journal, 2001
- HIFα Targeted for VHL-Mediated Destruction by Proline Hydroxylation: Implications for O 2 SensingScience, 2001
- Targeting of HIF-α to the von Hippel-Lindau Ubiquitylation Complex by O 2 -Regulated Prolyl HydroxylationScience, 2001
- Hypoxia Inducible Factor-α Binding and Ubiquitylation by the von Hippel-Lindau Tumor Suppressor ProteinJournal of Biological Chemistry, 2000
- Ubiquitination of hypoxia-inducible factor requires direct binding to the β-domain of the von Hippel–Lindau proteinNature Cell Biology, 2000